Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9336019rdf:typepubmed:Citationlld:pubmed
pubmed-article:9336019lifeskim:mentionsumls-concept:C0034836lld:lifeskim
pubmed-article:9336019lifeskim:mentionsumls-concept:C0260043lld:lifeskim
pubmed-article:9336019pubmed:issue1lld:pubmed
pubmed-article:9336019pubmed:dateCreated1997-11-14lld:pubmed
pubmed-article:9336019pubmed:abstractTextAt the neuromuscular junction, P2-purinoceptors mediate the actions of the co-transmitter ATP and P1-purinoceptors, those of its degradation product adenosine. The classification of the subtypes of P1- and P2-purinoceptors and their signal transduction routes is presented. Purinoceptor-mediated effects on the prejunctional release of acetylcholine and the postjunctional desensitization and expression of nicotinic receptors are discussed in depth. An additional section on the reversal action of the P2-purinoceptor antagonist suramin on neuromuscular block underscores the importance of testing purinoceptor-targeted drugs once they will be marketed, to avoid adverse effects in patients.lld:pubmed
pubmed-article:9336019pubmed:languageenglld:pubmed
pubmed-article:9336019pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9336019pubmed:citationSubsetIMlld:pubmed
pubmed-article:9336019pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9336019pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9336019pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9336019pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9336019pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9336019pubmed:statusMEDLINElld:pubmed
pubmed-article:9336019pubmed:issn0163-7258lld:pubmed
pubmed-article:9336019pubmed:authorpubmed-author:HenningR HRHlld:pubmed
pubmed-article:9336019pubmed:issnTypePrintlld:pubmed
pubmed-article:9336019pubmed:volume74lld:pubmed
pubmed-article:9336019pubmed:ownerNLMlld:pubmed
pubmed-article:9336019pubmed:authorsCompleteYlld:pubmed
pubmed-article:9336019pubmed:pagination115-28lld:pubmed
pubmed-article:9336019pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:9336019pubmed:meshHeadingpubmed-meshheading:9336019-...lld:pubmed
pubmed-article:9336019pubmed:meshHeadingpubmed-meshheading:9336019-...lld:pubmed
pubmed-article:9336019pubmed:meshHeadingpubmed-meshheading:9336019-...lld:pubmed
pubmed-article:9336019pubmed:meshHeadingpubmed-meshheading:9336019-...lld:pubmed
pubmed-article:9336019pubmed:meshHeadingpubmed-meshheading:9336019-...lld:pubmed
pubmed-article:9336019pubmed:meshHeadingpubmed-meshheading:9336019-...lld:pubmed
pubmed-article:9336019pubmed:meshHeadingpubmed-meshheading:9336019-...lld:pubmed
pubmed-article:9336019pubmed:meshHeadingpubmed-meshheading:9336019-...lld:pubmed
pubmed-article:9336019pubmed:meshHeadingpubmed-meshheading:9336019-...lld:pubmed
pubmed-article:9336019pubmed:meshHeadingpubmed-meshheading:9336019-...lld:pubmed
pubmed-article:9336019pubmed:meshHeadingpubmed-meshheading:9336019-...lld:pubmed
pubmed-article:9336019pubmed:meshHeadingpubmed-meshheading:9336019-...lld:pubmed
pubmed-article:9336019pubmed:year1997lld:pubmed
pubmed-article:9336019pubmed:articleTitlePurinoceptors in neuromuscular transmission.lld:pubmed
pubmed-article:9336019pubmed:affiliationDepartment of Clinical Pharmacology, University of Groningen, The Netherlands.lld:pubmed
pubmed-article:9336019pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9336019pubmed:publicationTypeReviewlld:pubmed
pubmed-article:9336019pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9336019lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9336019lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9336019lld:pubmed